TIDMEAH

RNS Number : 6926W

Eco Animal Health Group PLC

22 August 2022

22 August 2022

ECO Animal Health Group plc

("ECO", the "Company" or the "ECO Group") (AIM: EAH)

REVISED NOTICE OF RESULTS

ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, today announces a revised date for the publication of its preliminary results for the year ended 31 March 2022.

The Company's auditor, BDO LLP, has requested additional time to complete its audit completion procedures. As a result, the Company now expects to announce its final results on 31 August 2022.

As previously announced in the trading update on 8 August 2022, the Group expects to report full-year results for the year ended 31 March 2022 with revenue of approximately GBP82.2 million (2021: GBP105.6 million) and an EBITDA of approximately GBP6.4 million which includes an exchange rate gain of GBP1.0 million.

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR") as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

For further information please contact:

 
 ECO Animal Health Group plc 
  David Hallas (CEO) 
  Christopher Wilks (CFO)                       020 8447 8899 
 
   IFC Advisory 
   Graham Herring 
   Zach Cohen                                     020 3934 6630 
 
   Singer Capital Markets (Nominated Adviser 
   & Joint Broker) 
   Mark Taylor 
   George Tzimas                                  020 7496 3000 
 
   Investec (Joint Broker) 
   Gary Clarence 
   Brough Ransom                                  020 7597 5970 
   Carlo Spingardi 
 
   Peel Hunt LLP (Joint Broker) 
   Dr Christopher Golden 
   James Steel                                    020 7418 8900 
 
 
 Equity Developments 
  Hannah Crowe 
  Matt Evans            020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORBRGDIDBDDGDB

(END) Dow Jones Newswires

August 22, 2022 02:00 ET (06:00 GMT)

Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Eco Animal Health Charts.
Eco Animal Health (LSE:EAH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Eco Animal Health Charts.